Clinical trial
Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004867 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00004867 |
|---|---|
| Title | Positron Emission Tomography in Determining Stage of Esophageal Cancer |
| Official title | The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Carcinoma of the Thoracic Esophagus |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | conventional surgery, positron emission tomography, radionuclide imaging, fludeoxyglucose F 18, chemotherapy, Radiotherapy |
| Enrollment | 235 |
| Start date | Nov 1, 1999 |
| Primary completion | Jul 1, 2005 |
| Completion | Jan 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 24, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: